Mutual Pharmaceutical Co. v. Iyax Pharmaceuticals, Inc.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• permitting a Lanham Act false advertising claim where the FDA had determined the labeling requirements for the specific drug at issue
• permitting a Lanham Act claim where the court only needed to “verify whether defendants’ label conforms to what the FDA has already determined is required to be listed for [defendant’s drug], something which the Court can do without any need to interpret and then apply FDA regulations”
• “[C]ourts have refused to allow a Lanham Act claim to proceed where, in order to determine the falsity or misleading nature of the representation at issue, the court would be required to interpret and then apply [F]FDCA statutory or regulatory provisions.”
• discussing Cottrell and distinguishing Mylan

Source: CourtListener parenthetical corpus (CC0).